Amends the provisions for insurance coverage of mental health, mental illness, and substance use disorders.
Summary
This bill amends Rhode Island’s insurance parity law for mental health and substance use disorder treatment. It requires group health plans and individual or group health insurance plans to cover behavioral health treatment on the same terms and conditions as coverage for other illnesses, and it reinforces limits on annual or lifetime caps, financial requirements, and treatment limitations. The bill also specifies that coverage rules must be based on generally accepted standards of care, and it adds a detailed definition of that term.
The measure further directs payors to use recognized clinical criteria when setting levels of care for substance use disorder treatment and mental health treatment, including the American Society of Addiction Medicine criteria for substance use disorders. It also clarifies that medication-assisted treatment, opioid overdose treatment, and chronic addiction services are included within the appropriate coverage classification, and it adds a parity rule for cost-sharing on behavioral health counseling and medication maintenance visits when compared with primary care office visits. The bill takes effect upon passage.
Impact
The bill would strengthen and clarify Rhode Island insurance law governing mental health and substance use disorder coverage by tightening parity requirements for both group and individual health plans. It would affect insurers, health plans, and payors by limiting the use of more restrictive financial requirements, quantitative limits, and non-quantitative utilization management practices for behavioral health services, while also expanding statutory guidance on clinical criteria and cost-sharing. It also expressly includes certain evidence-based and medication-assisted treatments within covered classifications and adds coverage language for non-opioid pain treatment such as chiropractic care and osteopathic manipulative treatment when medically necessary.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears supportive of expanding and clarifying access to mental health and substance use disorder treatment coverage. The sponsors’ framing suggests a policy goal of stronger parity and more consistent insurance coverage standards. No opposing statements or recorded roll-call votes are included in the provided context, so there is no documented public controversy in the supplied record.
Contention
The main policy issues embedded in the bill concern how insurers define and apply clinical criteria, especially whether payors may use internal standards that are more restrictive than generally accepted standards of care. Another likely point of contention is the bill’s limits on non-quantitative treatment limitations, which could constrain insurer utilization review, network design, reimbursement methods, and provider credentialing practices. The inclusion of medication-assisted treatment, opioid-related care, and coverage for chiropractic or osteopathic manipulative treatment may also be debated by insurers or stakeholders concerned about cost, scope of coverage, or medical necessity standards.